Skip to main content
. 2022 Jan 28;42(1):BSR20212654. doi: 10.1042/BSR20212654

Table 4. Effect of citrate and NAD+/pyruvate on the diameters of human LDH-A association forms estimated by DLS experiments.

Sample Diameter (nm) Area (%)
Control pH 7.5
8 µM LDH (Holo)
10.96 (T) 42.4
9.25 (D) 45.9
7.98 (M) 12.0
Control pH 6.5
8 µM LDH (Holo)
11.25 (T) 5.7
9.14 (D) 94.6
Control pH 5.0
8 µM LDH (Holo)
9.52 (D) 73.9
8.40 (M) 26.5
Citrate pH 7.5
8 µM LDH (Holo)
10.07 (T) 40.3
9.27 (D) 56.9
8.40 (M) 2.9
Citrate pH 6.5
8 µM LDH (Holo)
10.45 (T) 45.6
9.04 (D) 42.3
8.00 M) 12.7
Citrate pH 5.0
8 µM LDH (Holo)
10.32 (T) 13.2
9.36 (D) 37.6
8.72 (M) 49.4
NAD/Pyr pH 7.5
8 µM LDH (Holo)
9.84 (T) 57.2
8.82 (D) 32.2
7.97 (M) 10.8
NAD/Pyr pH 6.5
8 µM LDH (Holo)
9.35 (D) 72.0
8.39 (M) 29.0
NAD/Pyr pH 5.0
8 µM LDH (Holo)
10.32 (T) 24.2
9.02 (D) 76.3

The distribution of the enzyme ensemble among different association forms was evaluated at the indicated pH values with LDH-A solutions supplemented with 2.5 mM citrate or with NAD+/pyruvate (2.5 and 0.5 mM, respectively). Control samples devoid of any additive were also analyzed. T, D, and M indicate the assignment of a detected component to enzyme tetramer, dimer, and monomer, respectively. In addition to the estimated diameters, the area of each component is also indicated.